Wolfgang Stöhr

3.4k total citations
65 papers, 1.6k citations indexed

About

Wolfgang Stöhr is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Wolfgang Stöhr has authored 65 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Infectious Diseases, 29 papers in Virology and 19 papers in Emergency Medicine. Recurrent topics in Wolfgang Stöhr's work include HIV/AIDS Research and Interventions (31 papers), HIV Research and Treatment (29 papers) and HIV/AIDS drug development and treatment (25 papers). Wolfgang Stöhr is often cited by papers focused on HIV/AIDS Research and Interventions (31 papers), HIV Research and Treatment (29 papers) and HIV/AIDS drug development and treatment (25 papers). Wolfgang Stöhr collaborates with scholars based in United Kingdom, Germany and Singapore. Wolfgang Stöhr's co-authors include Thorsten Langer, Jörn D. Beck, Stefan Bielack, Marios Paulides, David Dunn, H. Jürgens, Sarah Fidler, Paula Munderi, Charles F. Gilks and Martin Fisher and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Wolfgang Stöhr

63 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wolfgang Stöhr United Kingdom 22 889 691 348 282 233 65 1.6k
Enric Pedrol Spain 24 907 1.0× 772 1.1× 646 1.9× 484 1.7× 41 0.2× 91 1.8k
María Larrousse Spain 24 878 1.0× 464 0.7× 511 1.5× 630 2.2× 72 0.3× 50 1.7k
Vani Vannappagari United States 14 418 0.5× 209 0.3× 157 0.5× 190 0.7× 423 1.8× 71 1.3k
Clotilde Allavena France 24 1.2k 1.3× 850 1.2× 474 1.4× 601 2.1× 75 0.3× 112 1.9k
Vanessa C. Williams United States 18 458 0.5× 336 0.5× 415 1.2× 97 0.3× 52 0.2× 33 1.4k
M Vial France 17 351 0.4× 222 0.3× 84 0.2× 295 1.0× 219 0.9× 59 1.1k
Nicholas I. Paton United Kingdom 18 1.4k 1.6× 1.4k 2.0× 1.7k 4.9× 493 1.7× 58 0.2× 39 2.7k
Federica Carli Italy 21 1.1k 1.2× 597 0.9× 1.6k 4.6× 644 2.3× 82 0.4× 42 2.2k
Vincenzo Colangeli Italy 25 1.2k 1.4× 822 1.2× 775 2.2× 436 1.5× 46 0.2× 81 2.0k
Nikolas Wada United States 13 535 0.6× 369 0.5× 419 1.2× 313 1.1× 87 0.4× 17 980

Countries citing papers authored by Wolfgang Stöhr

Since Specialization
Citations

This map shows the geographic impact of Wolfgang Stöhr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolfgang Stöhr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolfgang Stöhr more than expected).

Fields of papers citing papers by Wolfgang Stöhr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wolfgang Stöhr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolfgang Stöhr. The network helps show where Wolfgang Stöhr may publish in the future.

Co-authorship network of co-authors of Wolfgang Stöhr

This figure shows the co-authorship network connecting the top 25 collaborators of Wolfgang Stöhr. A scholar is included among the top collaborators of Wolfgang Stöhr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wolfgang Stöhr. Wolfgang Stöhr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alagaratnam, Jasmini, Wolfgang Stöhr, Elizabeth Hamlyn, et al.. (2024). Impact of interrupting antiretroviral therapy started during primary HIV-1 infection on plasma neurofilament light chain protein, a marker of neuronal injury: The SPARTAC trial. Journal of Virus Eradication. 10(2). 100381–100381. 1 indexed citations
2.
Turner, Rebecca, A. Sarah Walker, Sally Ellis, et al.. (2024). Determining sample size in a personalized randomized controlled (PRACTical) trial. Statistics in Medicine. 43(21). 4098–4112. 2 indexed citations
3.
Hart, Melanie, Mark Gompels, Alan Winston, et al.. (2023). Peripheral Neuropathy in Virologically Suppressed People Living with HIV: Evidence from the PIVOT Trial. Viruses. 16(1). 2–2.
4.
Bielicki, Julia, David Dunn, Saul N. Faust, et al.. (2021). Amoxicillin duration and dose for community-acquired pneumonia in children: the CAP-IT factorial non-inferiority RCT. Health Technology Assessment. 25(60). 1–72. 7 indexed citations
5.
6.
Moore, Cecilia L., Wolfgang Stöhr, Angela M. Crook, et al.. (2019). Multi-arm, multi-stage randomised controlled trials for evaluating therapeutic HIV cure interventions. The Lancet HIV. 6(5). e334–e340. 6 indexed citations
7.
Mancini, Emiliano, Rick Quax, Andrea De Luca, et al.. (2018). A study on the dynamics of temporary HIV treatment to assess the controversial outcomes of clinical trials: An in-silico approach. PLoS ONE. 13(7). e0200892–e0200892. 7 indexed citations
8.
Haddow, Lewis, Claudia Godi, Magdalena Sokolska, et al.. (2018). Brain Perfusion, Regional Volumes, and Cognitive Function in Human Immunodeficiency Virus–positive Patients Treated With Protease Inhibitor Monotherapy. Clinical Infectious Diseases. 68(6). 1031–1040. 2 indexed citations
9.
Walker, Simon, Wolfgang Stöhr, David Dunn, et al.. (2016). Cost Effectiveness of Protease Inhibitor Monotherapy Versus Standard Triple Therapy in the Long-Term Management of HIV Patients: Analysis Using Evidence from the PIVOT Trial. PharmacoEconomics. 34(8). 795–804. 7 indexed citations
10.
11.
Winston, Alan, Wolfgang Stöhr, Andrea Antinori, et al.. (2016). Changes in Cognitive Function Over 96 Weeks in Naive Patients Randomized to Darunavir–Ritonavir Plus Either Raltegravir or Tenofovir–Emtricitabine: A Substudy of the NEAT001/ANRS143 Trial. JAIDS Journal of Acquired Immune Deficiency Syndromes. 74(2). 185–192. 8 indexed citations
12.
Williams, James P., Jacob Hurst, Wolfgang Stöhr, et al.. (2014). HIV-1 DNA predicts disease progression and post-treatment virological control. eLife. 3. e03821–e03821. 201 indexed citations
13.
Walker, Susan, et al.. (2014). Cost-Effectiveness Analysis of Protease Inhibitor Monotherapy Verse Ongoing Triple-Therapy in the Long-Term Management of HIV Patients. Value in Health. 17(7). A683–A683. 1 indexed citations
14.
Paulides, Marios, Wolfgang Stöhr, Hans‐Jürgen Laws, et al.. (2011). Antibody levels against tetanus and diphtheria after polychemotherapy for childhood sarcoma: A report from the Late Effects Surveillance System. Vaccine. 29(8). 1565–1568. 8 indexed citations
15.
Stöhr, Wolfgang, Andrew Reid, A. Sarah Walker, et al.. (2011). Glomerular Dysfunction and Associated Risk Factors over 4–5 Years following Antiretroviral Therapy Initiation in Africa. Antiviral Therapy. 16(7). 1011–1020. 30 indexed citations
16.
Stöhr, Wolfgang, David Dunn, Kholoud Porter, et al.. (2007). CD4 cell count and initiation of antiretroviral therapy: trends in seven UK centres, 1997–2003. HIV Medicine. 8(3). 135–141. 33 indexed citations
17.
18.
Ssali, Francis, Wolfgang Stöhr, Paula Munderi, et al.. (2006). Prevalence, Incidence and Predictors of Severe Anaemia with Zidovudine-Containing Regimens in African Adults with HIV Infection within the Dart Trial. Antiviral Therapy. 11(6). 741–750. 75 indexed citations
19.
Stöhr, Wolfgang, A Sarah Walker, Francis Ssali, et al.. (2006). Glomerular Dysfunction and associated Risk Factors following Initiation of ART in Adults with HIV Infection in Africa: a subanalysis in the DART Trial.. 4 indexed citations
20.
Stöhr, Wolfgang, et al.. (1981). Mosel - Saar - Ruwer. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Enric Pedrol Breakdown of academic impact, for papers by María Larrousse Breakdown of academic impact, for papers by Vani Vannappagari Breakdown of academic impact, for papers by Clotilde Allavena Breakdown of academic impact, for papers by Vanessa C. Williams Breakdown of academic impact, for papers by M Vial Breakdown of academic impact, for papers by Nicholas I. Paton Breakdown of academic impact, for papers by Federica Carli Breakdown of academic impact, for papers by Vincenzo Colangeli Breakdown of academic impact, for papers by Nikolas Wada
Rankless by CCL
2026